The global gene therapy cell culture media industry generated $122.60 million in 2019, and is projected to reach $278.96 million by 2027, witnessing a CAGR of 10.6% from 2020 to 2027.
Rise in R&D investments, surge in awareness regarding gene therapy, advancements related to gene therapy, and increase in prevalence of cancer drive the growth of the global gene therapy cell culture media market. However, scarcity of skilled professionals, high costs related to gene therapies, and ethical & scientific concerns regarding culture media hinder the market growth. On the other hand, untapped potential of the emerging countries present new opportunities in the coming years.
Increase in investments and funding for R&D, innovation in life sciences act as the major driving forces of the global gene therapy cell culture media market. Furthermore, growth in awareness regarding gene therapy is expected to rise in demand notably contribute toward the growth of the market.
By end user, it is divided into research institutes, pharmaceutical & biotechnology companies and academic institutes. By region, the gene therapy cell culture media market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, India, Australia, South Korea and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa and rest of LAMEA).
The adenoviruses segment to maintain its lead position by 2027
Based on viral vectors type, the adenoviruses segment accounted for the highest share in 2019, contributed to more than one-fifth of the global gene therapy cell culture media market, and is estimated to maintain its lead position by 2027. This is attributed to increase in government support and ethical acceptance of gene therapy for cancer treatment. Moreover, the lentiviruses segment is expected to manifest the largest CAGR of 18.0% during the forecast period. This is due to increase in prevalence of genetic disorders, cancer, and infectious diseases along with rise in number of clinical studies.
North America to maintain its dominance in terms of revenue throughout the forecast period
Based on region, North America contributed to the highest market share in 2019, accounting for nearly half of the global gene therapy cell culture media market, and will maintain its dominance in terms of revenue throughout the forecast period. This is attributed to increase in production capacity for viral gene and virally modified cell therapy products along with presence of majority of key players. However, Asia-Pacific is estimated to register the fastest CAGR of 13.5% from 2020 to 2027, owing to rise in awareness regarding gene therapy for cancer treatment, development of the R&D sector, and surge in research funding.
Leading market players
- Fujifilm Holdings Corporation
- HiMedia Laboratories Pvt. Ltd.
- Lonza Group Ltd.
- Sartorius AG
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Danaher Corporation
- Takara Holdings Inc.
- Novartis International AG
- Bio-Techne Corporation
Read More: https://www.alliedmarketresearch.com/press-release/gene-therapy-cell-culture-media-market.html
0 Comments